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Abstract
© 2016 The Authors. Published under the terms of the CC BY 4.0 licenseLung cancer (LC) is the
leading cause of cancer-related deaths worldwide. Early LC diagnosis is crucial to reduce the
high case fatality rate of this disease. In this case–control study, we developed an accurate LC
diagnosis test using retrospectively collected formalin-fixed paraffin-embedded (FFPE) human
lung  tissues  and  prospectively  collected  exhaled  breath  condensates  (EBCs).  Following
international guidelines for diagnostic methods with clinical application, reproducible standard
operating  procedures  (SOP)  were  established  for  every  step  comprising  our  LC  diagnosis
method. We analyzed the expression of distinct mRNAs expressed from GATA6 and NKX2-1, key
regulators of lung development. The Em/Ad expression ratios of GATA6 and NKX2-1 detected in
EBCs were combined using linear kernel support vector machines (SVM) into the LC score, which
can be used for LC detection. LC score-based diagnosis achieved a high performance in an
independent validation cohort. We propose our method as a non-invasive, accurate, and low-
price option to complement the success of computed tomography imaging (CT) and chest X-ray
(CXR) for LC diagnosis.
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